Bernhard Hoffmann - 18 Jan 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: SVP of Corp. Dev.
Signature: /s/ Emily Johns, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 18 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 22 Jan 2024, 18:01:13 UTC
Previous filing: 12 Jan 2024
Next filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+20,000	+14%	$0.000000	162,697	18 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+30,000		$0.000000	30,000	18 Jan 2024	Common Stock	30,000	$2.77	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
F2	The option will vest with respect to 7,500 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.